Conference Programs to Accelerate Your Biologics Research
May 10-14, 2027
Boston, MA + Virtual
Omni Boston Hotel at the Seaport
For more than two decades, PEGS Boston has been the leading conference for the biologics community and brought together scientists and innovators advancing biologics from discovery through development. Explore the latest breakthroughs in protein and antibody engineering, immunotherapy, peptide drug development, T-cell engagers, and AI/ML-enabled biologics research.
Gain actionable insights from leading experts, discover technologies accelerating biologics development, and connect with the researchers and industry leaders driving innovation across the field.
Learn from leaders. Connect with innovators. Drive biologics forward.
PEGS BOSTON 2026 KEYNOTE SESSIONS
PLENARY KEYNOTE
CARs 2026: New Models and New Runways
Michel Sadelain, MD, PhD
Director, Columbia University Initiative in Cell Engineering and Therapy (CICET); Director, Cell Therapy Initiative, Herbert Irving Comprehensive Cancer Center; Professor of Medicine; Columbia University Irving Medical Center
2026 YOUNG SCIENTIST KEYNOTE
Deep Learning-based Binder Design to Probe Biology
Martin Pacesa, PhD
Assistant Professor, Pharmacology, University of Zurich
PLENARY FIRESIDE CHAT:
How to Think About Designing Smart Biologics in the Age of GenAI: Integrating Biology, Technology, and Experience
MODERATOR:
Christopher Langmead, PhD
AI-Driven Molecular Design, Danaher Corporation
PANELISTS:
Surge Biswas, PhD
Founder & CEO, Nabla Bio
Rebecca Croasdale-Wood, PhD
Senior Director, Augmented Biologics Discovery & Design, Biologics Engineering, Oncology, AstraZeneca
Joshua Meier, PhD
Co-Founder, Chai Discovery
Maria Wendt, PhD
Global Head, Preclinical Computational Innovation Strategy Research Platforms, R&D, Sanofi
PEGS YOUNG SCIENTIST KEYNOTE ALUMNI PANEL:
Innovation in Protein Science with Young Scientist Visionaries
MODERATOR:
James A. Wells, PhD
Professor, University of California, San Francisco
PANELISTS:
Martin Pacesa, PhD
Assistant Professor, Pharmacology, University of Zurich
Jamie Spangler, PhD
Associate Professor, Johns Hopkins University
Kipp Weiskopf, MD, PhD
Head of Antibody Therapeutics and Biologics, Cancer Research Institute, Beth Israel Deaconess Medical Center
Timothy Whitehead, PhD
Professor, University of Colorado
Xin Zhou, PhD
Assistant Professor, Harvard Medical School
Michel Sadelain, PhD
Columbia University Irving Medical Center
Puja Sapra, PhD
AstraZeneca Pharmaceuticals, Inc.
Marcella V. Maus, MD, PhD
Massachusetts General Hospital
“PEGS is always a wonderful experience. It's an opportunity to connect with colleagues and peers as well as a chance to see the pulse of the industry.”
Jacob W., Scientific Consultant, Genedata
“Excellent opportunity to hear about current innovations in the biologics field and network with knowledgeable experts in a smaller setting.”
Jutta D., VP, R&D, Iksuda Therapeutics
“PEGS Boston is a must for anyone working in this industry.”
Michael F., CSO, AbAb
“From philosophical to practical and even instrumental, PEGS Boston offered a tremendous opportunity for professional development.”
Jackson B., Senior Research Scientist, New England Biolabs
Whether you’re targeting the entire conference community of life sciences, pharmaceutical, clinical, healthcare, and IT professionals, a topic-specific community, a specific individual, or high-level decision makers, we offer a variety of methods to access our esteemed delegates. Explore our sponsor or exhibitor packages which offer a wide range of platforms to launch products, gain exposure, collect feedback, network and generate new leads.
